- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Report sees cardiac ultrasound growth
A new report published by Frost & Sullivan of Mountain View,CA, predicts that ultrasound's share of the cardiac imaging marketwill grow in coming years, while that of x-ray and nuclear medicinedeclines. The publication claims that the worldwide
A new report published by Frost & Sullivan of Mountain View,CA, predicts that ultrasound's share of the cardiac imaging marketwill grow in coming years, while that of x-ray and nuclear medicinedeclines. The publication claims that the worldwide market forcardiac medical imaging equipment will hit $2.09 billion in revenuesin 2002, compared with $1.66 billion last year: a 3% annual growthrate.
The report, entitled World Cardiac Diagnostic Imaging EquipmentMarket, states that echocardiography's market share in cardiacimaging will rise from 38% in 1995 to 41% in 2002, while cardiac-basedx-ray will fall from 43% to 42% and nuclear medicine will declinefrom 13% to 12% in the same period. CT had 4% of the cardiac imagingmarket in 1995 and MRI had 2%.
Frost & Sullivan researchers believe that the move towardless invasive procedures will benefit other modalities at theexpense of x-ray catheterization, with echocardiography and cardiacMRI being major beneficiaries.
Prices have eroded 25% over the last three years in some cardiacimaging segments, according to the report.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
